1. The efficacy of ustekinumab on the articular and dermatologic manifestations of psoriatic arthritis

   • Arthur Kavanaugh

   Clinical Trials Report 18 August 2009 Pages: 233 - 234

2. What was wrong and might now go right with clinical trials for lupus?

   • Joan T. Merrill

   Current Reports / Rheumatology / Invited Commentary 18 August 2009 Pages: 235 - 237

3. Atherosclerosis risk factors in systemic lupus erythematosus

   • Surabhi Agarwal
   • Jennifer R. Elliott
   • Susan Manzi

   OriginalPaper 18 August 2009 Pages: 241 - 247

4. Epidemiology of atherosclerosis in systemic lupus erythematosus

   • Mandana Nikpour
   • Murray B. Urowitz
   • Dafna D. Gladman

   OriginalPaper 18 August 2009 Pages: 248 - 254

5. Effects of inflammation on cholesterol metabolism: Impact on systemic lupus erythematosus

   • Allison B. Reiss

   OriginalPaper 18 August 2009 Pages: 255 - 260

6. Psoriatic arthritis: Pharmacoeconomic considerations

   • Ignazio Olivieri
   • Lorenzo Giovanni Mantovani
   • Simona de Portu

   OriginalPaper 18 August 2009 Pages: 263 - 269

7. Update on the treatment of peripheral arthritis in psoriatic arthritis

   • Enrique R. Soriano
   • Javier Rosa

   OriginalPaper 18 August 2009 Pages: 270 - 277

8. Assessment and treatment of psoriatic spondylitis

   • Peter Nash

   OriginalPaper 18 August 2009 Pages: 278 - 283

9. Genetic risk and protective factors for the idiopathic inflammatory myopathies

   • Terrance P. O’Hanlon
   • Frederick W. Miller

   OriginalPaper 18 August 2009 Pages: 287 - 294

10. The inflammatory milieu in idiopathic inflammatory myositis

    • Ann M. Reed
    • Floranne Ernste

    OriginalPaper 18 August 2009 Pages: 295 - 301

11. Ultrasound in the evaluation of the inflammatory myopathies

    • Ronald S. Adler
    • Giovanna Garofalo

    OriginalPaper 18 August 2009 Pages: 302 - 308